Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
16,463,909
-
Total 13F shares
-
24,839,747
-
Share change
-
+2,149,354
-
Total reported value
-
$731,027,543
-
Put/Call ratio
-
61%
-
Price per share
-
$31.05
-
Number of holders
-
104
-
Value change
-
+$65,328,555
-
Number of buys
-
69
-
Number of sells
-
44
Institutional Holders of RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share (RAPT) as of Q3 2021
As of 30 Sep 2021,
RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share (RAPT) was held by
104 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,839,747 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, PERCEPTIVE ADVISORS LLC, BlackRock Inc., Ponoi Management, LLC, WELLINGTON MANAGEMENT GROUP LLP, KPCB XV Associates, LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., FMR LLC, VANGUARD GROUP INC, and MORGAN STANLEY.
This page lists
104
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.